Chloramphenicol-containing drugs. A report from Spain

Area of Science:

• Pharmacology
• Drug Composition Analysis
• Regulatory Science

Background:

• Chloramphenicol is a broad-spectrum antibiotic.
• Combination drug products are common in pharmaceutical markets.
• Accurate and comprehensive drug information is vital for safe medical practice.

Purpose of the Study:

• To analyze the composition of Spanish chloramphenicol-containing compounds.
• To evaluate the information provided in package inserts for these drugs.
• To identify discrepancies between listed indications and established medical uses.

Main Methods:

• Review of 185 Spanish pharmaceutical compounds containing chloramphenicol.
• Analysis of package insert information regarding indications, side effects, contraindications, and precautions.
• Comparison of listed indications with medically established uses of chloramphenicol.

Main Results:

• Only 11 out of 185 compounds contained chloramphenicol as a sole active ingredient.
• The majority of products were combinations with other therapeutic agents.
• Package inserts frequently listed indications beyond established medical uses.
• Information on side effects, contraindications, and precautions was often insufficient or unclear.

Conclusions:

• There is a need to reassess the availability of chloramphenicol combination products.
• Improvement in the quality and completeness of information provided in drug package inserts is urgently required.
• Enhanced regulatory oversight may be necessary to ensure accurate drug information and appropriate usage.